Mechanical Circulatory Support

Orange 24 surrounded by headset, represents "Place an order"

Contact Customer Service

Our customer service experts can help with your product orders or questions.

Featured Mechanical Circulatory Support Product

Designed for a range of heart failure patients 

Our mechanical circulatory support devices are designed to support a broad range of advanced heart failure patients.

HeartMate II™ LVAD provides treatment options for both you and your patients living with advanced heart failure. The HeartMate II LVAD is indicated for both destination therapy and bridge-to-transplantation therapy in the United States. Over 25,000 heart failure patients have received the HeartMate II LVAD. Many have passed the 5-year milestone on therapy and some are still on therapy after 10 years.*

The HeartMate 3 Left Ventricular Assist System is indicated for providing short-term hemodynamic support (e.g., bridge to transplant or bridge to myocardial recovery) in patients with advanced refractory left ventricular heart failure.

The CentriMag™ acute circulatory support system is driven by Full MagLev™ flow technology for optimal hemocompatibility, delivering excellent results in the widest range of patient applications.

The mechanical circulatory support device featured here represents a solution with our latest technologies. You can find additional heart failure management products in our full product catalog

*Data on file. SJM-HM-1016-0031(1)

Left Ventricular Assist Device

See All >
HeartMate 3™ left ventricular assist system (LVAS) for advanced heart failure patients

HeartMate 3™ Left Ventricular Assist Device

HeartMate 3™ LVAD with Full MagLev Flow Technology is a new milestone in LVAD therapy that delivers better blood handling through meaningful innovation.*,**,1

*At the 6-month primary endpoint in the MOMENTUM 3 trial. (MOMENTUM 3 = Multicenter Study of Maglev Technology in Patients Undergoing Mehcanical Circulatory Support Therapy with HeartMate 3 LVAD.)
**As defined by zero incidence of pump thrombosis in the MOMENTUM 3 trial at 6 months.
1. Mehra, M. R., Yoshifumi, N., Uriel, N., Goldstein, D. J., Cleveland, J. C. Jr., Colombo, Paolo C., … Salerno, C. for the MOMENTUM 3 Investigators. (2016, November 16). A fully magnetically levitated circulatory pump for advanced heart failure. The New England Journal of Medicine, 376,440-50.

HeartMate II™ left ventricular assist system (LVAS) behind pocket-sized controller

HeartMate II™ Left Ventricular Assist System

The HeartMate II™ left ventricular assist system (LVAS) is designed to provide long-term circulatory support to intermediate-to-chronic heart failure patients. Its small, quiet pump features a simple design and provides blood flow equivalent to that of a healthy heart.

Acute Circulatory Support System

See All >

CentriMag™ Acute Circulatory Support System

The CentriMag™ acute circulatory support system with Full MagLev™ flow technology delivers excellent hemocompatibility across the widest range of patient applications, and is designed to meet your individualized clinical preferences and needs.1-3

1. John, R., Long, J. W., Massey, H. T., Griffith, B. P., Sun, B. C., Tector, A. J., … Joyce, L. D. (2011). Outcomes of a multicenter trial of the Levitronix CentriMag ventricular assist system for short-term circulatory support. The Journal of Thoracic and Cardiovascular Surgery, 141(4), 932-939.
2. John, R., Liao, K., Lietz, K., Kandar, F., Colvin-Adams, M., Boyle, A., … Joyce, L. (2007). Experience with the Levitronix CentriMag circulatory support system as a bridge to decision in patients with refractory acute cardiogenic shock and multisystem organ failure. The Journal of Thoracic and Cardiovascular Surgery, 134(2), 351-358.
3. Zhang, J., Gellman, B., Koert, A., Dasse, K. A., Gilbert, R. J., Griffith, B. P., & Wu, Z. J. (2006). Computational and experimental evaluation of the fluid dynamics and hemocompatibility of the CentriMag blood pump. Artificial Organs, 30(3), 168-177.